Articles dans des revues avec comité de lecture (196)
  1. 13. Hederman, A. P., Natarajan, H., Heyndrickx, L., Ariën, K. K., Wiener, J. A., Wright, P. F., Bloch, E. M., Tobian, A. A. R., Redd, A. D., Blankson, J. N., Rottenstreich, A., Zarbiv, G., Wolf, D., Goetghebuer, T., Marchant, A., & Ackerman, M. M. (2023). SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations. Nature communications, 14(1), 5171. doi:10.1038/s41467-023-40960-0
  2. 14. Taton, M., Willems, F., Widomski, C., Martin, C., Jiang, Y., Renard, K., Cogan, A., Necsoi, C. V., Ackerman, M. M., Marchant, A., & Dauby, N. (2023). Impact of pregnancy on polyfunctional IgG and memory B cell responses to Tdap immunization. Vaccine. doi:10.1016/j.vaccine.2023.05.035
  3. 15. Pannus, P., Depickère, S., Kemlin, D., Georges, D., Houben, S., Olislagers, V., Waegemans, A., De Craeye, S., Francotte, A., Chaumont, F., Van Oostveldt, C., Heyndrickx, L., Michiels, J., Willems, E., Dhondt, E., Krauchuk, M., Schmickler, M.-N., Verbrugghe, M., Van Loon, N., Dierick, K., Matagne, A., Desombere, I., Ariën, K. K., Marchant, A., & Goossens, M. M. (2023). Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults. Vaccine, 41(17), 2829-2836. doi:10.1016/j.vaccine.2023.03.047
  4. 16. Erdem, R., De Coster, I., Withanage, K., Mercer, L. L., Marchant, A., Taton, M., Cools, N., Lion, E., Cassels, F., Higgins, D., Ivinson, K., Locke, E., Mahmood, K., Wright, P. F., Gast, C., White, J. A., Ackerman, M. M., Konopka-Anstadt, J. J., Mainou, B. B., & Van Damme, P. (2023). Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized study. Vaccine, 41(10), 1657-1667. doi:10.1016/j.vaccine.2023.01.048
  5. 17. Kemlin, D., Gemander, N., Depickère, S., Olislagers, V., Georges, D., Waegemans, A., Pannus, P., Lemy, A., Goossens, M. M., Desombere, I., Michiels, J., Vandevenne, M., Heyndrickx, L., Ariën, K. K., Matagne, A., Ackerman, M. M., Le Moine, A., & Marchant, A. (2023). Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients. American Journal of Transplantation. doi:10.1016/j.ajt.2023.02.015
  6. 18. Thiriard, A., Meyer, B., Eberhardt, C. S., Loevy, N., Grazioli, S., Adouan, W., Fontannaz, P., Marechal, F., L'Huillier, A. G., Siegrist, C.-A., Georges, D., Putignano, A., Marchant, A., Didierlaurent, A. M., & Blanchard-Rohner, G. (2023). Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19. Frontiers in immunology, 14, 1107156. doi:10.3389/fimmu.2023.1107156
  7. 19. Ariën, K., Heyndrickx, L., Michiels, J., Vereecken, K., Van Lent, K., Coppens, S., Willems, B., Pannus, P., Martens, G. A., Van-Esbroeck, M., Goossens, M. M., Marchant, A., Bartholomeeusen, K., & Desombere, I. (2022). Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant. NPJ vaccines, 7(1), 35. doi:10.1038/s41541-022-00459-z
  8. 20. Strandmark, J., Darboe, A., Diray-Arce, J., Ben-Othman, R., Vignolo, S. S., Rao, S., Smolen, K., Leroux-Roels, G., Idoko, O. T., Sanchez-Schmitz, G., Ozonoff, A., Levy, O., Kollmann, T. R., Marchant, A., & Kampmann, B. (2022). A single birth dose of Hepatitis B vaccine induces polyfunctional CD4+ T helper cells. Frontiers in immunology, 13, 1043375. doi:10.3389/fimmu.2022.1043375
  9. 21. Tomasi, L., Thiriard, A., Heyndrickx, L., Georges, D., Van den Wijngaert, S., Olislagers, V., Sharma, S., Matagne, A., Ackerman, M. M., Ariën, K. K., Goetghebuer, T., & Marchant, A. (2022). Younger Children Develop Higher Effector Antibody Responses to SARS-CoV-2 Infection. Open Forum Infectious Diseases, 9(11), ofac554. doi:10.1093/ofid/ofac554
  10. 22. Bharadwaj, P., Shrestha, S., Pongracz, T., Concetta, C., Sharma, S., Le Moine, A., de Haan, N., Murakami, N., Riella, L. L., Holovska, V., Wuhrer, M., Marchant, A., & Ackerman, M. M. (2022). Afucosylation of HLA-specific IgG1 as a potential predictor of antibody pathogenicity in kidney transplantation. Cell reports. Medicine, 3(11), 100818. doi:10.1016/j.xcrm.2022.100818
  11. 23. Lavis, P., Morra, S., Orte Cano, C., Albayrak, N., Corbiere, V., Olislagers, V., Dauby, N., Del Marmol, V., Marchant, A., Decaestecker, C., Mascart, F., De Vos, N., Van De Borne, P., Salmon, I., Remmelink, M., Parmentier, M., Cardozo, A. K., & Bondue, B. (2022). Chemerin plasma levels are increased in COVID-19 patients and are an independent risk factor of mortality. Frontiers in immunology, 13, 941663. doi:10.3389/fimmu.2022.941663
  12. 24. Taylor, S. A., Sharma, S., Remmel, C. C., Holder, B., Jones, C. E., Marchant, A., & Ackerman, M. M. (2022). HIV-Associated Alterations of the Biophysical Features of Maternal Antibodies Correlate With Their Reduced Transfer Across the Placenta. The Journal of infectious diseases, 226(8), 1441-1450. doi:10.1093/infdis/jiac222
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Suivant >>